0001104659-20-097591.txt : 20200821
0001104659-20-097591.hdr.sgml : 20200821
20200821161529
ACCESSION NUMBER: 0001104659-20-097591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200819
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cavan John T
CENTRAL INDEX KEY: 0001503738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36856
FILM NUMBER: 201123562
MAIL ADDRESS:
STREET 1: C/O STEMLINE THERAPEUTICS, INC.
STREET 2: 750 LEXINGTON AVENUE, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001583771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462783806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
BUSINESS PHONE: 732-902-4000
MAIL ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
FORMER COMPANY:
FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130806
4
1
a4.xml
4
X0306
4
2020-08-19
0
0001583771
Hepion Pharmaceuticals, Inc.
HEPA
0001503738
Cavan John T
C/O HEPION PHARMACEUTICALS, INC.
399 THORNALL STREET, FIRST FLOOR
EDISON
NJ
08837
0
1
0
0
Chief Financial Officer
Stock Options
3.72
2020-08-19
4
A
0
160000
0
A
2030-08-19
Common Stock
160000
381060
D
53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.
/s/ John Cavan
2020-08-21